PACAP Enhances Barrier Properties of Cerebral Microvessels

Journal of Molecular Neuroscience

Volumn 54, Issue 3, 2014, Pages 469-476

  Wilhelm, Imola ^a   Fazakas, Csilla ^a   Tamás, Andrea ^b   Tóth, Gábor ^c   Reglődi, Dóra ^b   Krizbai, István A ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Blood brain barrier (BBB); Cerebral microvascular endothelial cell; Cyclic adenosine monophosphate (cAMP); Pituitary adenylate cyclase activating polypeptide (PACAP); Tight junctions; Transendothelial electrical resistance (TEER)

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1;

ANIMAL; APOPTOSIS; ASTROCYTE; BLOOD BRAIN BARRIER; CELL CULTURE; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; HUMAN; METABOLISM; MICROVASCULATURE; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; APOPTOSIS; ASTROCYTES; BLOOD-BRAIN BARRIER; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MICROVESSELS; OXIDATIVE STRESS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I;

EID: 84895418512     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0260-4     Document Type: Article

References (32)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13–25
2. Banks WA, Kastin AJ, Komaki G, Arimura A (1993) Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther 267:690–696
3. Basille M, Cartier D, Vaudry D et al (2006) Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development. J Comp Neurol 496:468–478
4. Brown D, Tamas A, Reglodi D, Tizabi Y (2013) PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson’s disease. J Mol Neurosci 50:600–607
5. Castorina A, Giunta S, Mazzone V, Cardile V, D’Agata V (2010) Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells. Peptides 31:2276–2283
6. Dogrukol-Ak D, Kumar VB, Ryerse JS et al (2009) Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models. J Cereb Blood Flow Metab 29:411–422
7. Erdling A, Sheykhzade M, Maddahi A, Bari F, Edvinsson L (2013) VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium. Neuropeptides 47:85–92
8. Giunta S, Castorina A, Bucolo C, Magro G, Drago F, D’Agata V (2012) Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats. Peptides 37:32–39
9. Grimaldi M, Cavallaro S (1999) Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11:2767–2772
10. Horai S, Nakagawa S, Tanaka K et al (2013) Cilostazol strengthens barrier integrity in brain endothelial cells. Cell Mol Neurobiol 33:291–307
11. Hutamekalin P, Farkas AE, Orbok A et al (2008) Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells. Cell Biol Int 32:198–209
12. Ishizaki T, Chiba H, Kojima T et al (2003) Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res 290:275–288
13. Jaworski DM (2000) Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury. Cell Tissue Res 300:219–230
14. Kis B, Gaspar T, Mezei Z, Gecse A, Telegdy G (1999) Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels. Acta Physiol Scand 167:43–47
15. Kis B, Deli MA, Kobayashi H et al (2001) Adrenomedullin regulates blood-brain barrier functions in vitro. Neuroreport 12:4139–4142
16. Krizbai IA, Deli MA (2003) Signalling pathways regulating the tight junction permeability in the blood-brain barrier. Cell Mol Biol (Noisy-Le-Grand) 49:23–31
17. Lenti L, Domoki F, Kis D et al (2007) Pituitary adenylate cyclase-activating polypeptide induces pial arteriolar vasodilation through cyclooxygenase-dependent and independent mechanisms in newborn pigs. Brain Res 1165:81–88
18. Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567–574
19. Paolinelli R, Corada M, Ferrarini L et al (2013) Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 8:e70233
20. Racz B, Gasz B, Borsiczky B et al (2007) Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Gen Comp Endocrinol 153:115–123
21. Reglodi D, Kiss P, Szabadfi K et al (2012) PACAP is an endogenous protective factor-insights from PACAP-deficient mice. J Mol Neurosci 48:482–492
22. Rubin LL, Staddon JM (1999) The cell biology of the blood-brain barrier. Annu Rev Neurosci 22:11–28
23. Rubin LL, Hall DE, Porter S et al (1991) A cell culture model of the blood-brain barrier. J Cell Biol 115:1725–1735
24. Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17:204–214
25. Stelzner TJ, Weil JV, O’Brien RF (1989) Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol 139:157–166
26. Sziraki I, Erdo F, Beery E et al (2011) Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study. J Biomol Screen 16:886–894
27. Tripathy D, Sanchez A, Yin X, Martinez J, Grammas P (2012) Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen. Microvasc Res 84:278–285
28. Tsuchikawa D, Nakamachi T, Tsuchida M et al (2012) Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury. J Mol Neurosci 48:508–517
29. Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357
30. Weksler BB, Subileau EA, Perriere N et al (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19:1872–1874
31. Wilhelm I, Farkas AE, Nagyoszi P et al (2007) Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol 52:6261–6274
32. Wilhelm I, Fazakas C, Krizbai IA (2011) In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 71:113–128